Deck Kelly
Insider CIK 1819427 · INBX Chief Financial Officer · INXB Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INBX Inhibrx Biosciences, Inc. | A Award deriv | 2025-04-01 | 2025-04-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INXB Inhibrx Biosciences, Inc. | A Award deriv | 2024-05-30 | 2024-05-30 | 175,000 | — | $0 | 175,000 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 21,250 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 9,167 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | D To issuer deriv | 2024-05-30 | 2024-05-30 | 14,583 | — | $0 | 0 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-05-06 | 2024-05-08 | 2,087 | $34.24 | $71.5K | 0 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-05-06 | 2024-05-08 | 17,624 | $34.24 | $603.4K | 0 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-26 | 2024-03-28 | 416 | $35.40 | $14.7K | 9,167 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-26 | 2024-03-28 | 396 | $35.40 | $14.0K | 17,624 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-26 | 2024-03-28 | 1,459 | $35.40 | $51.6K | 14,583 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-26 | 2024-03-28 | 625 | $35.40 | $22.1K | 21,250 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-22 | 2024-03-22 | 110 | $35.00 | $3.9K | 18,020 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-21 | 2024-03-22 | 3,113 | $35.09 | $109.2K | 18,130 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-20 | 2024-03-22 | 16,777 | $35.02 | $587.5K | 21,243 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-13 | 2024-03-15 | 32,431 | $35.43 | $1.15M | 2,087 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-08 | 2024-03-12 | 42,523 | $35.75 | $1.52M | 38,020 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-05 | 2024-03-06 | 10,417 | $35.72 | $372.1K | 9,583 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-04 | 2024-03-06 | 53,958 | $35.40 | $1.91M | 16,042 | SEC↗ |
| INBX Inhibrx, Inc. | M Exercise deriv | 2024-03-04 | 2024-03-06 | 8,125 | $35.60 | $289.3K | 21,875 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2023-01-03 | 2023-01-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2022-01-11 | 2022-01-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INBX Inhibrx, Inc. | A Award deriv | 2021-01-15 | 2021-01-19 | 70,000 | — | $0 | 70,000 | SEC↗ |